AptarGroup, Inc.

NYSE:ATR

Medical - Instruments & Supplies

Healthcare
$141.67 +0.55%

+$0.66 today

Market cap
$8.98B
Beta
0.40
P/E (TTM)
20.0
EPS (TTM)
$6.04
Dividend yield
1.57%
52W Low $103.23High $164.28

Volume 0.34M

Average 0.51M

ATR Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

AptarGroup, Inc.NYSE: ATR

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization grows in line with its trailing trend

Q2 FY2026 depreciation & amortization of $79.64M rose 13.9% year over year, in line with the +13.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.2% from the prior quarter. Over 3 fiscal years it compounded at +7.1% a year.

Context

  • Depreciation & amortization amounted to 7.6% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +13.9% holds above the trailing-twelve-month pace of +13.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$79.64M+5.2% QoQ
Last fiscal yearDec 2025
$287.36M+8.9% YoY
LTMJun 2026
$307.18M+13.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.9%——
1 year+8.9%——
3-year CAGR+7.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
287.36M USD
Year-over-year change
+8.9%
4-year CAGR
+5.2%

Depreciation & Amortization vs competitors

How ATR compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +13.8% is the 2nd highest of 7, against a peer median of +9.8%.
  • Depreciation & amortization amounts to 7.8% of revenue for ATR, versus a peer median of 6.7%.
ATR Competitors
Depreciation & Amortization for ATR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMCRAmcor plcLTM Jun 2026$1.58B USD+119.1%+36.2%6.7%
SONSonoco Products CompanyLTM Sep 2026$527.72M USD+8.4%+18.9%7.2%
SLGNSilgan Holdings Inc.LTM Jun 2026$332.51M USD+11.1%+6.7%5.0%
ATRAptarGroup, Inc.LTM Jun 2026$307.18M USD+13.8%+7.1%7.8%
WSTWest Pharmaceutical Services, Inc.LTM Jun 2026$180.8M USD+11.4%+12.4%5.4%
STVNStevanato Group S.p.A.LTM Jun 2026€95.21M EUR-22.5%+11.0%7.8%
TRSTriMas CorporationLTM Mar 2026$57.72M USD-10.6%+2.3%6.7%
Peer median (excluding ATR) —+9.8%+11.7%6.7%

Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.23B3.32B3.49B3.58B3.78B
Cost of Revenue2.07B2.16B2.22B2.23B2.66B
Gross Profit1.16B1.16B1.26B1.36B1.12B
Gross Margin35.8%35.0%36.2%37.8%29.6%
Research & Development99.8M000105.1M
Selling, General & Admin551.24M544.26M565.78M582.23M499.94M
Operating Expenses809.34M784.57M859.38M859.01M605.04M
Depreciation & Amortization234.85M233.71M248.59M263.78M287.36M
EBITDA586.79M609.41M663.84M777.45M831.48M
EBITDA Margin18.2%18.3%19.0%21.7%22.0%
Operating Income347.35M379.27M404.02M496.5M512.34M
Operating Margin10.8%11.4%11.6%13.9%13.6%
Interest Income3.67M2.7M4.37M12.1M11.68M
Interest Expense30.28M40.83M40.42M43.9M52.74M
Other Income / Expenses(25.69M)(44.57M)(29.19M)(26.73M)(20.96M)
Income Before Tax321.66M334.7M374.83M469.77M491.38M
Pre-Tax Margin10.0%10.1%10.7%13.1%13.0%
Income Tax Expense78.02M95.15M90.65M95.59M98.88M
Net Income244.1M239.29M284.49M374.54M392.79M
Net Margin7.6%7.2%8.2%10.5%10.4%
EPS (Basic)3.723.664.345.655.97
EPS (Diluted)3.603.594.255.535.88
Weighted Avg Shares65.66M65.4M65.62M66.33M65.74M
Weighted Avg Shares (Diluted)67.68M66.72M66.91M67.69M66.72M

AptarGroup, Inc.

NYSE:ATR

Intrinsic Alpha fair value

Locked

Current Price

$141.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.